Company info

NewLimit is a biotechnology company working to radically extend human healthspan. We’re developing medicines to treat aging by reprogramming the epigenome, a new therapeutic mechanism to restore youthful function in aged cells. We’ve built the world’s leading experimental and artificial intelligence system to discover reprogramming medicines at massive scale. Our first products are focused on restoring youthful metabolic, endothelial, and immune function.

Description

NewLimit is recruiting a Director / Senior Director of Clinical Operations to orchestrate and manage our first clinical trials. Our most advanced assets restore youthful hepatic metabolism and hold the potential to benefit diverse populations with liver disease and metabolic dysfunction. Our early stage programs have similar potential for impact in renal and inflammatory disease indications.

In this role, you will orchestrate and manage clinical trials for some of the world’s first reprogramming medicines.

As part of the role, you will:

• Lead clinical trial execution through protocol development, CRO selection and management, and startup activities across several geographies (US, AUS/NZ, EU, UK)
• Collaborate with clinical development to ensure trial designs and execution provide maximum benefit to patients and maximum information per dollar</